Cerebral radiation necrosis: Incidence, outcomes, and risk factors with emphasis on radiation parameters and chemotherapy

International Journal of Radiation Oncology Biology Physics

Volumn 65, Issue 2, 2006, Pages 499-508

  Ruben, Jeremy D ^a   Dally, Michael ^a   Bailey, Michael ^b   Smith, Robin ^a   McLean, Catriona A ^c   Fedele, Pasqual ^d  

^a William Buckland Radiotherapy Centre   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c ALFRED HOSPITAL   (Australia)

^d MONASH UNIVERSITY   (Australia)

Author keywords

Brain; Chemotherapy; Glioma; Radiation injury; Radiation necrosis

Indexed keywords

BRAIN; CHEMOTHERAPY; REGRESSION ANALYSIS; RISK ASSESSMENT;

GLIOMA; RADIATION INJURY; RADIATION NECROSIS;

RADIOTHERAPY;

ANTICONVULSIVE AGENT; CARMUSTINE; LOMUSTINE; PHENOBARBITAL; PROCARBAZINE; STEROID; TEMOZOLOMIDE; VALPROIC ACID; VINCRISTINE;

ADULT; ARTICLE; BRAIN NECROSIS; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CAUSE OF DEATH; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; GLIOBLASTOMA; GLIOMA; HIGH RISK POPULATION; HUMAN; INCIDENCE; LOGISTIC REGRESSION ANALYSIS; MALE; MEDICAL RECORD; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION NECROSIS; RISK FACTOR; SURVIVAL RATE; TREATMENT OUTCOME;

ADULT; BRAIN; BRAIN NEOPLASMS; CRANIAL IRRADIATION; FEMALE; GLIOMA; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NECROSIS; RADIATION INJURIES; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; STATISTICS; TIME FACTORS;

EID: 33646234949     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2005.12.002     Document Type: Article

References (78)

1. Laperriere N., Zuraw L., and Cairncross G. Radiotherapy for newly diagnosed malignant glioma in adults. A systematic review. Radiother Oncol 64 (2002) 259-273
2. CBTRUS. Statistical report: Primary brain tumors in the United States, 1997-2001. Chicago, IL: Central Brain Tumor Registry of the United States; 2004-2005.
3. Surawicz T.S., McCarthy B.J., Kupelian V., et al. Descriptive epidemiology of primary brain and CNS tumors. Results from the Central Brain Tumor Registry of the United States, 1990-1994. Neuro-oncol 1 (1999) 14-25
4. Walker M.D., Alexander Jr. E., Hunt W.E., et al. Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial. J Neurosurg 49 (1978) 333-343
5. Walker M.D., Green S.B., Byar D.P., et al. Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. N Engl J Med 303 (1980) 1323-1329
6. Kristiansen K., Hagen S., Kollevold T., et al. Combined modality therapy of operated astrocytomas grade III and IV. Confirmation of the value of postoperative irradiation and lack of potentiation of bleomycin on survival time: A prospective multicenter trial of the Scandinavian Glioblastoma Study Group. Cancer 47 (1981) 649-652
7. Sandberg-Wollheim M., Malmstrom P., Stromblad L.G., et al. A randomized study of chemotherapy with procarbazine, vincristine, and lomustine with and without radiation therapy for astrocytoma grades 3 and/or 4. Cancer 68 (1991) 22-29
8. Shapiro W.R., and Young D.F. Treatment of malignant glioma. A controlled study of chemotherapy and irradiation. Arch Neurol 33 (1976) 494-500
9. Grossman S.A., and Batara J.F. Current management of glioblastoma multiforme. Semin Oncol 31 (2004) 635-644
10. Shaw E., Arusell R., Scheithauer B., et al. Prospective randomized trial of low- versus high-dose radiation therapy in adults with supratentorial low-grade glioma. Initial report of a North Central Cancer Treatment Group/Radiation Therapy Oncology Group/Eastern Cooperative Oncology Group study. J Clin Oncol 20 (2002) 2267-2276
11. Karim A.B., Maat B., Hatlevoll R., et al. A randomized trial on dose-response in radiation therapy of low-grade cerebral glioma. European Organization for Research and Treatment of Cancer (EORTC) Study 22844. Int J Radiat Oncol Biol Phys 36 (1996) 549-556
12. Bleehen N.M., Stenning S.P., and The Medical Research Council Brain Tumour Working Party. A Medical Research Council trial of two radiotherapy doses in the treatment of grades 3 and 4 astrocytoma. Br J Cancer 64 (1991) 769-774
13. Walker M.D., Strike T.A., and Sheline G.E. An analysis of dose-effect relationship in the radiotherapy of malignant gliomas. Int J Radiat Oncol Biol Phys 5 (1979) 1725-1731
14. Coffey R.J., Lunsford L.D., and Taylor F.H. Survival after stereotactic biopsy of malignant gliomas. Neurosurgery 22 (1988) 465-473
15. Fischer A., and Holfelder H. Lokales amyloid in Gehirn [Local amyloid in the brain]. Dtsch Z Chir 227 (1930) 475-483
16. Bampoe J., Nag S., Leung P., et al. Brain necrosis after permanent low-activity iodine-125 implants. Case report and review of toxicity from focal radiation. Brain Tumor Pathol 17 (2000) 139-145
17. Hoshi M., Hayashi T., Kagami H., et al. Late bilateral temporal lobe necrosis after conventional radiotherapy. Neurol Med Chir (Tokyo) 43 (2003) 213-216
18. Coghlan K.M., and Magennis P. Cerebral radionecrosis following the treatment of parotid tumors. A case report and review of the literature. Int J Oral Maxillofac Surg 28 (1999) 50-52
19. Glass J.P., Hwang T.L., Leavens M.E., et al. Cerebral radiation necrosis following treatment of extracranial malignancies. Cancer 54 (1984) 1966-1972
20. Lee A.W., Foo W., Chappell R., et al. Effect of time, dose, and fractionation on temporal lobe necrosis following radiotherapy for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 40 (1998) 35-42
21. Marks J.E., Baglan R.J., Prassad S.C., et al. Cerebral radionecrosis. Incidence and risk in relation to dose, time, fractionation and volume. Int J Radiat Oncol Biol Phys 7 (1981) 243-252
22. Morris J.G., Grattan-Smith P., Panegyres P.K., et al. Delayed cerebral radiation necrosis. Q J Med 87 (1994) 119-129
23. Sheline G.E., Wara W.M., and Smith V. Therapeutic irradiation and brain injury. Int J Radiat Oncol Biol Phys 6 (1980) 1215-1228
24. Kramer S. The hazards of therapeutic irradiation of the central nervous system. Clin Neurosurg 15 (1968) 301-318
25. Liebel S., and Sheline G. Tolerance of the brain and spinal cord to conventional irradiation. In: Sheline G.E. (Ed). Radiation injury to the nervous system (1991), Raven Press, New York 239-256
26. Mikhael M.A. Dosimetric considerations in the diagnosis of radiation necrosis of the brain. In: Kagan A. (Ed). Radiation damage to the nervous system. A delayed therapeutic hazard (1980), Raven Press, New York 59-91
27. Marsa G.W., Goffinet D.R., Rubinstein L.J., et al. Megavoltage irradiation in the treatment of gliomas of the brain and spinal cord. Cancer 36 (1975) 1681-1689
28. Soffietti R., Sciolla R., Giordana M.T., et al. Delayed adverse effects after irradiation of gliomas. Clinicopathological analysis. J Neurooncol 3 (1985) 187-192
29. Kumar A.J., Leeds N.E., Fuller G.N., et al. Malignant gliomas. MR imaging spectrum of radiation therapy- and chemotherapy-induced necrosis of the brain after treatment. Radiology 217 (2000) 377-384
30. Shaw E., Scott C., Souhami L., et al. Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases. Final report of RTOG protocol 90-05. Int J Radiat Oncol Biol Phys 47 (2000) 291-298
31. Lee A.W., Kwong D.L., Leung S.F., et al. Factors affecting risk of symptomatic temporal lobe necrosis. Significance of fractional dose and treatment time. Int J Radiat Oncol Biol Phys 53 (2002) 75-85
32. Kramer S. The hazards of therapeutic irradiation of the central nervous system. Clin Neurosurg 15 (1968) 301-318
33. al-Mefty O., Kersh J.E., Routh A., et al. The long-term side effects of radiation therapy for benign brain tumors in adults. J Neurosurg 73 (1990) 502-512
34. Shrieve D.C., Alexander III E., Black P.M., et al. Treatment of patients with primary glioblastoma multiforme with standard postoperative radiotherapy and radiosurgical boost. Prognostic factors and long-term outcome. J Neurosurg 90 (1999) 72-77
35. Wowra B., Schmitt H.P., and Sturm V. Incidence of late radiation necrosis with transient mass effect after interstitial low dose rate radiotherapy for cerebral gliomas. Acta Neurochir (Wien) 99 (1989) 104-108
36. Gutin P.H., Prados M.D., Phillips T.L., et al. External irradiation followed by an interstitial high-activity iodine-125 implant "boost" in the initial treatment of malignant gliomas. NCOG study 6G-82-2. Int J Radiat Oncol Biol Phys 21 (1991) 601-606
37. Leibel S.A., Gutin P.H., Wara W.M., et al. Survival and quality of life after interstitial implantation of removable high-activity iodine-125 sources for the treatment of patients with recurrent malignant gliomas. Int J Radiat Oncol Biol Phys 17 (1989) 1129-1139
38. Burger P.C., Mahley Jr. M.S., Dudka L., et al. The morphologic effects of radiation administered therapeutically for intracranial gliomas. A postmortem study of 25 cases. Cancer 44 (1979) 1256-1272
39. Rubinstein J.L., Herman M.M., Long T.F., et al. Leukoencephalopathy following combined therapy of central nervous system leukemia and lymphoma. Acta Neuropathol Suppl (Berl) Suppl. 6 (1975) 251-255
40. Edwards M., and Wilson C. Treatment of radiation necrosis. In: Kagan A. (Ed). Radiation damage to the nervous system (1980), Raven Press, New York 129-153
41. Floyd N.S., Woo S.Y., Teh B.S., et al. Hypofractionated intensity-modulated radiotherapy for primary glioblastoma multiforme. Int J Radiat Oncol Biol Phys 58 (2004) 721-726
42. Forsyth P.A., Kelly P.J., Cascino T.L., et al. Radiation necrosis or glioma recurrence. Is computer-assisted stereotactic biopsy useful?. J Neurosurg 82 (1995) 436-444
43. Kramer S., Southard M., and Mansfield C. Radiation effect and tolerance of the central nervous system. Front Rad Ther Oncol 6 (1972) 332-345
44. van der Kogel A. The nervous system. Radiobiology and experimental pathology. In: Scherer E., Streffe C., and Trott K.R. (Eds). Radiopathology of organs and tissues (1991), Springer-Verlag, Berlin 191-212
45. Becker G., Kocher M., Kortmann R.D., et al. Radiation therapy in the multimodal treatment approach of pituitary adenoma. Strahlenther Onkol 178 (2002) 173-186
46. Zaugg M., Adaman O., Pescia R., et al. External irradiation of macroinvasive pituitary adenomas with telecobalt. A retrospective study with long-term follow-up in patients irradiated with doses mostly of between 40-45 Gy. Int J Radiat Oncol Biol Phys 32 (1995) 671-680
47. Stupp R., Mason W.P., van den Bent M.J., et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352 (2005) 987-996
48. Mahaley Jr. M.S., Whaley R.A., Blue M., et al. Central neurotoxicity following intracarotid BCNU chemotherapy for malignant gliomas. J Neurooncol 3 (1986) 297-314
49. Di Chiro G., Oldfield E., Wright D.C., et al. Cerebral necrosis after radiotherapy and/or intraarterial chemotherapy for brain tumors. PET and neuropathologic studies. Am J Roentgenol 150 (1988) 189-197
50. Allen J.C., Rosen G., Mehta B.M., et al. Leukoencephalopathy following high-dose iv methotrexate chemotherapy with leucovorin rescue. Cancer Treat Rep 64 (1980) 1261-1273
51. Allen J.C., Thaler H.T., Deck M.D., et al. Leukoencephalopathy following high-dose intravenous methotrexate chemotherapy. Quantitative assessment of white matter attenuation using computed tomography. Neuroradiology 16 (1978) 44-47
52. Safdari H., Fuentes J.M., Dubois J.B., et al. Radiation necrosis of the brain. Time of onset and incidence related to total dose and fractionation of radiation. Neuroradiology 27 (1985) 44-47
53. Rubinstein L.J., Herman M.M., Long T.F., et al. Disseminated necrotizing leukoencephalopathy. A complication of treated central nervous system leukemia and lymphoma. Cancer 35 (1975) 291-305
54. Souhami L., Seiferheld W., Brachman D., et al. Randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with glioblastoma multiforme. Report of Radiation Therapy Oncology Group 93-05 protocol. Int J Radiat Oncol Biol Phys 60 (2004) 853-860
55. Herrmann T., Voigtmann L., Knorr A., et al. The time-dose relationship for radiation-induced lung damage in pigs. Radiother Oncol 5 (1986) 127-135
56. Overgaard J., Hansen H.S., Specht L., et al. Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck. DAHANCA 6 and 7 randomised controlled trial. Lancet 362 (2003) 933-940
57. Fu K.K., Pajak T.F., Trotti A., et al. A Radiation Therapy Oncology Group (RTOG) Phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head-and-neck squamous cell carcinomas. First report of RTOG 9003. Int J Radiat Oncol Biol Phys 48 (2000) 7-16
58. Bourhis J., Calais G., Lapeyre M., et al. Concomitant radiochemotherapy or accelerated radiotherapy. Analysis of two randomized trials of the French Head and Neck Cancer Group (GORTEC). Semin Oncol 31 (2004) 822-826
59. Taylor J.M., Mendenhall W.M., and Lavey R.S. Dose, time, and fraction size issues for late effects in head-and-neck cancers. Int J Radiat Oncol Biol Phys 22 (1992) 3-11
60. Hornsey S., Myers R., Coultas P.G., et al. Turnover of proliferative cells in the spinal cord after X irradiation and its relation to time-dependent repair of radiation damage. Br J Radiol 54 (1981) 1081-1085
61. Field S.B., and Hornsey S. Slow repair after x-rays and fast neutrons. Br J Radiol 50 (1977) 600-601
62. Chappell R., Nondahl D.M., Rezvani M., et al. Further analysis of radiobiological parameters from the First and Second British Institute of Radiology randomized studies of larynx/pharynx radiotherapy. Int J Radiat Oncol Biol Phys 33 (1995) 509-518
63. Horiot J.C., Bontemps P., van den Bogaert W., et al. Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers. Results of the EORTC 22851 randomized trial. Radiother Oncol 44 (1997) 111-121
64. Jen Y.M., Hsu W.L., Chen C.Y., et al. Different risks of symptomatic brain necrosis in NPC patients treated with different altered fractionated radiotherapy techniques. Int J Radiat Oncol Biol Phys 51 (2001) 344-348
65. Babu R., Huang P.P., Epstein F., et al. Late radiation necrosis of the brain. Case report. J Neurooncol 17 (1993) 37-42
66. Woo E., Lam K., Yu Y.L., et al. Temporal lobe and hypothalamic-pituitary dysfunctions after radiotherapy for nasopharyngeal carcinoma. A distinct clinical syndrome. J Neurol Neurosurg Psychiatry 51 (1988) 1302-1307
67. Kulinskii V.I., and Klimova A.D. [The radioprotective effect of GABA-tropic substances, gamma-hydroxybutyrate and piracetam]. Radiobiologiia 33 (1993) 133-136
68. Grattan-Smith P.J., Morris J.G., and Langlands A.O. Delayed radiation necrosis of the central nervous system in patients irradiated for pituitary tumours. J Neurol Neurosurg Psychiatry 55 (1992) 949-955
69. Aristizabal S.A., Boone M.L., and Laguna J.F. Endocrine factors influencing radiation injury to central nervous tissue. Int J Radiat Oncol Biol Phys 5 (1979) 349-353
70. Hopewell J.W., and Wright E.A. The nature of latent cerebral irradiation damage and its modification by hypertension. Br J Radiol 43 (1970) 161-167
71. Ehrenfeld C.E., Maschke M., Dorfler A., et al. Is stereotactic biopsy a reliable method to differentiate tumor from radiation necrosis?. Clin Neuropathol 21 (2002) 9-12
72. Gutin P. Treatment of radiation necrosis of the brain. In: Sheline G.E. (Ed). Radiation injury to the nervous system (1991), Raven Press, New York 271-281
73. Woo E., Lam K., Yu Y.L., et al. Cerebral radionecrosis. Is surgery necessary?. J Neurol Neurosurg Psychiatry 50 (1987) 1407-1414
74. Lee A.W., Ng S.H., Ho J.H., et al. Clinical diagnosis of late temporal lobe necrosis following radiation therapy for nasopharyngeal carcinoma. Cancer 61 (1988) 1535-1542
75. Shaw P.J., and Bates D. Conservative treatment of delayed cerebral radiation necrosis. J Neurol Neurosurg Psychiatry 47 (1984) 1338-1341
76. Marks M.P., Delapaz R.L., Fabrikant J.I., et al. Intracranial vascular malformations: Imaging of charged-particle radiosurgery. Part II. Complications. Radiology 168 (1988) 457-462
77. Joiner M.C., and Bentzen S.M. Time-dose relationships. The linear-quadratic approach. In: Steele G.G. (Ed). Basic clinical radiobiology. 3rd ed. (2002), Arnold, London 120-133
78. Steele G.G. The dose rate effect. Brachytherapy and targeted radiotherapy. In: Steele G.G. (Ed). Basic clinical radiobiology (2002), Arnold, London 192-204